Compare · 2 funds side by side · dividends reinvested

PSCH and ARKG

PSCHInvesco×ARKGARK×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$9,299PSCH · best of the two

02 / 04

PSCH and ARKG, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Invesco S&P SmallCap Health Care ETFSectors · Health care0.29%0.00%+25.9%+31.0%+16.9%−1.4%−15.4%19.6%$178M1.4

ARK Genomic Revolution ETFSectors · Health care0.75%0.00%+70.9%+59.0%+30.6%−8.0%−27.5%45.8%$2.2B1.6

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: PSCH 2010 · ARKG 2014

Head to Head

Swap sides Versus in desk

Head to Head

Invesco S&P SmallCap Health Care ETF · $178M$9,299

PSCH

ARKG

ARK Genomic Revolution ETF · $2.2B$6,586

$10,000 five years ago, dividends reinvested · they hold 2.8% in common

PSCHMeasureARKG

+25.9%Year to dateJan 1 → Nov 3+70.9%

+31.0%1 yearTotal return+59.0%

+16.9%3 years · per year$10,000 became $15,990 · $22,262+30.6%

−1.4%5 years · per year$10,000 became $9,299 · $6,586−8.0%

0.29%Expense ratio$29 · $75 a year on $10k · lower is better0.75%

0.00%Trailing 12-mo yield$0 · $0 a year on $10k0.00%

−15.4%Worst dropSmaller is better−27.5%

19.6%VolatilityLower is calmer45.8%

PSCHARKG Winner of the row, in its colourEach row: the bigger of the two fills its side

4–3PSCH wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

PSCH vs ARKG: Top 5 Holdings

Today

PSCH

23.2%in top 5

ARKG

in top 535.4%

PSCHStockARKG

not top 5TEM9.8%

not top 5TXG7.5%

not top 5TWST7.4%

7.2%GKOSnot top 5

not top 5CRSP5.5%

not top 5GH5.1%

4.6%PTGXnot top 5

4.4%TGTXnot top 5

3.9%ALKSnot top 5

3.1%LGNDnot top 5

Held in common2.8%

End-of-day Nov 3, 2026 · share of each fund

PSCH vs ARKG Returns, Every Period

InvescoPSCH

−1.4%

5 years, per year

ARKGARK

−8.0%

5 years, per year

PSCHARKGFaded: behind in that period

1–3ARKG wins

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

PSCH vs ARKG

YTD

InvescoPSCH

+25.9%

ARKGARK

+70.9%

+25.9%Year to date+70.9%

−15.4%Worst drop · 1Y−27.5%

19.6%Volatility · 1Y45.8%

0.0%Yield0.0%

$178MAssets$2.2B

2–1PSCH wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: PSCH, ARKG

Today

0.29%lowest, PSCH

FundExpense ratioFee$10k

PSCH0.29%$29

ARKG0.75%$75

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: PSCH, ARKG

0.00%highest, PSCH

FundTrailing yieldYield$10k

PSCH0.00%$0

ARKG0.00%$0

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

−$29most kept, PSCH

PSCH$0 − $29 = −$29

ARKG$0 − $75 = −$75

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: PSCH, ARKG

Today

2.8%most shared, PSCH and ARKG

PSCHARKG

PSCH—2.8%

ARKG2.8%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+59.0%ARKG, at 45.8% volatility

PSCHWorst drop−15.4%19.6% vol

ARKGWorst drop−27.5%45.8% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

PSCHARKG

+25.9%Year to date+70.9%

0.0%Yield0.0%

+31.0%Past year+59.0%

0.29%Fee0.75%

2–1ARKG wins

End-of-day Nov 3, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026